Subutex (Buprenorphine) Treatment
Subutex (also known as Buprenorphine) is an effective, safe medication approved by the FDA for use in the treatment of opioid addiction. Focus offers Buprenorphine during medical detoxification to relieve withdrawal symptoms, reduce cravings and block the effects of other opioids.
How Subutex (Buprenorphine) Works
The way in which opioids affect the brain can be explained using a lock and key analogy. The opioid receptor is like a lock. Only the right key will fit perfectly into the lock, only opioid drugs fit into the opioid receptors. With full opioid agonists such as methadone, heroin, oxycodone, or morphine, the key will fit the lock perfectly, and fully stimulate the receptor thereby producing full opioid effects such as euphoria or “feeling high” and produces the side effects such as respiratory depression and sedation. These drugs have the greatest abuse potential. With a partial agonist like Buprenorphine, the key fits the lock but not as well as the full opioid agonist, so it produces limited effects, enough to prevent withdrawal and cravings but not enough to cause intense euphoria. Buprenorphine does not allow other opioids to enter the receptor and can also displace other opioids from the receptor.
The agonist effects of Buprenorphine increase with increasing doses. At a certain point, however, the increasing effects of the Buprenorphine reach maximum levels and do not increase further, even if the dose continues to rise creating a “ceiling effect”. This ceiling effect makes Buprenorphine safer, making it less likely to produce opioid overdose and reducing its potential street value, Buprenorphine carries a lower risk of abuse, addiction, and side effects compared to full opioid agonists.